TY  - RPRT
TI  - CRISPR-Engineered CAR-T Cell Therapy for Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: A Review of Emerging Therapeutic Prospects.
AU  - Noor Allehyani
AU  - Mohammed Alissa
AU  - Abdullah Alghamdi
AU  - Mohammed A Alshehri
AU  - Ghadah S Abusalim
AU  - Alaa S Alhegaili
AU  - Tawfiq N Juraybi
AU  - Meshari A Alsuwat
PY  - 2026
DO  - 10.1002/rmv.70199
UR  - https://pubmed.ncbi.nlm.nih.gov/42700448/
ID  - 42700448
ER  -